{"id":3790,"count":5,"description":"Hipotiroidismul \u2014 tiroid\u0103 hipoactiv\u0103 \u2014 afecteaz\u0103 aproximativ 5% din adul\u021bi la nivel mondial<\/strong>, femeile fiind diagnosticate de cinci p\u00e2n\u0103 la zece ori mai frecvent dec\u00e2t b\u0103rba\u021bii. Tiroid\u0103 este situat\u0103 \u00een partea anterioar\u0103 a g\u00e2tului \u0219i produce doi hormoni: tiroxin\u0103 (T4)<\/strong> \u0219i triiodotironin\u0103 (T3)<\/strong>, care \u00eempreun\u0103 regleaz\u0103 rata metabolic\u0103 a fiec\u0103rei celule din organism. C\u00e2nd glanda nu func\u021bioneaz\u0103 corespunz\u0103tor \u2013 cel mai frecvent din cauza distrugerii autoimune (tiroidita Hashimoto), interven\u021biei chirurgicale pentru noduli sau cancer, abl\u0103rii cu radioiod, absen\u021bei congenitale sau deficien\u021bei severe de iod \u2013 simptomele apar treptat: oboseal\u0103, cre\u0219tere \u00een greutate, intoleran\u021b\u0103 la frig, constipa\u021bie, piele uscat\u0103, c\u0103dere de p\u0103r, depresie \u0219i cea\u021b\u0103 mental\u0103. Hipotiroidismul netratat \u00een timpul sarcinii cre\u0219te riscul de avort spontan \u0219i afecteaz\u0103 dezvoltarea neurologic\u0103 a fetusului. Diagnosticul este biochimic: un nivel crescut de hormon stimulator al tiroidei (TSH)<\/strong> cu un nivel sc\u0103zut sau la limita inferioar\u0103 a normalului al T4 liber<\/strong>.\n\nTreatment is hormone replacement. The first-line drug is levotiroxina<\/strong> — synthetic T4 — taken once daily on an empty stomach. Levothyroxine has a long half-life (~7 days) which produces smooth blood levels with simple once-daily dosing. The body converts T4 to the more active T3 in peripheral tissues exactly as it does with the natural hormone, which is why most patients feel completely well on T4 alone. Dose is titrated against TSH every 6–8 weeks until the level sits in the target range (usually 0.5–2.5 mIU\/L), then monitored annually.\n\nLevothyroxine (T4) brands stocked at MedsBase\nAll four brands below contain the identical active ingredient — levotiroxin\u0103 sodic\u0103<\/strong>. Ele difer\u0103 prin produc\u0103tor, excipien\u021bi \u0219i pre\u021b. Odat\u0103 ce TSH-ul t\u0103u se stabilizeaz\u0103 cu o anumit\u0103 marc\u0103, men\u021binerea acesteia evit\u0103 mici varia\u021bii de bioechivalen\u021b\u0103 care pot duce la dep\u0103\u0219irea intervalului \u021bint\u0103 pentru TSH.\n\nEltroxin<\/strong><\/a> \u2014 GlaxoSmithKline (GSK), comprimat de 100 mcg. Marc\u0103 recunoscut\u0103 la nivel mondial, utilizat\u0103 \u00eenc\u0103 din anii 1960; aceea\u0219i molecul\u0103 ca Synthroid \u0219i Levoxyl.\n0,5 mg, 1 mg, 2 mg<\/strong><\/a> \u2014 Abbott India, gam\u0103 complet\u0103 de titrare 25\/50\/100\/125\/150 mcg. Cea mai prescris\u0103 levotiroxin\u0103 \u00een India.\nThyrox<\/strong><\/a> \u2014 Macleods Pharmaceuticals, 25\/100\/125\/200 mcg. Include doza mai mare de 200 mcg, util\u0103 pentru suprima\u021bia TSH-ului post-tiroidectomie.\nL-Thyroid<\/strong><\/a> — budget option, full 25 to 150 mcg titration range.\n\n\nLiothyronine (T3) — second-line\nLiotironin\u0103 25 mcg<\/strong><\/a> is synthetic T3 — about four times more potent than levothyroxine, with a much shorter half-life (~24 hours). Liothyronine bypasses the T4-to-T3 conversion step entirely. Its place in therapy is narrow:\n\nA doz\u0103 mic\u0103 ad\u0103ugat\u0103 al\u0103turi de levotiroxin\u0103<\/strong> in selected patients with persistent hypothyroid symptoms despite a normal TSH on T4 monotherapy — usually a specialist endocrinology decision after other causes are excluded.\nShort-term preg\u0103tire pentru investiga\u021bii imagistice \u00een cancerul tiroidian<\/strong> (permite cre\u0219terea mai rapid\u0103 a TSH-ului dup\u0103 \u00eentrerupere).\nComa mixedematoas\u0103<\/strong> in hospital, given intravenously alongside T4.\nOff-label augmentation in depresie rezistent\u0103 la tratament<\/strong>.\n\nLiothyronine is prime\u0219te,<\/strong> a wholesale replacement for levothyroxine and is not a weight-loss drug — misuse in euthyroid people causes atrial fibrillation, bone loss and muscle wasting. The Cochrane systematic review found no consistent benefit of T4+T3 over T4 monotherapy for routine quality-of-life improvement.\n\nThyroid nutritional support — not a treatment substitute\nThyropace<\/strong><\/a> este un supliment alimentar sub form\u0103 de capsule cu L-Tirozin\u0103 + Iod. Este inclus \u00een aceast\u0103 categorie deoarece sus\u021bine func\u021bia tiroidian\u0103 din punct de vedere nutri\u021bional, dar nu este prime\u0219te,<\/strong> a substitute for levothyroxine in diagnosed hypothyroidism. Thyropace can be appropriate for confirmed mild iodine deficiency or as adjunct nutritional support during pregnancy. It should be avoided in autoimmune Hashimoto’s thyroiditis, Graves’ disease, and before radioiodine scanning — excess iodine flares autoimmunity and complicates radio-tracer imaging.\n\nCritical absorption rules for any T4 or T3 product\nLevothyroxine and liothyronine absorption are dramatically reduced by food, coffee, soy and several common medications. The rules below are essential, not optional:\n\nTake on an stomac gol<\/strong>, first thing in the morning, with plain water.\nWait 30\u201360 de minute<\/strong> before any food, coffee or other tablet.\nSeparate from calciu, fier, magneziu, zinc, aluminiu<\/strong> supplements \/ antacids by at least 4 hours.\nSeparate from inhibitori ai pompei de protoni<\/strong> (omeprazole, esomeprazole, pantoprazole) — gastric acid is needed for full absorption.\nSeparate from colestiramin\u0103, sevelamer, orlistat<\/strong> cu cel pu\u021bin 4 ore \u00eenainte.\nSarcina:<\/strong> necesarul de levotiroxin\u0103 cre\u0219te cu 25\u201350% p\u00e2n\u0103 la mijlocul sarcinii \u2014 verifica\u021bi TSH la fiecare 4 s\u0103pt\u0103m\u00e2ni \u00een prima jum\u0103tate a sarcinii.\nPacien\u021bi \u00een v\u00e2rst\u0103 \/ pacien\u021bi cardiaci:<\/strong> start low (25–50 mcg) and titrate slowly to avoid triggering ischaemia or atrial fibrillation.\n\n\nEvery product in this category is dispatched from a produc\u0103tor certificat WHO-GMP<\/strong>, generic aprobat de FDA unde este aplicabil, cu ambalaj discret \u0219i livrare la nivel mondial. Fiecare pagin\u0103 de produs include un tabel de titrare TSH, lista complet\u0103 de interac\u021biuni medicamentoase, profilul efectelor secundare prin supra- sau sub-tratare \u0219i un panou cu alternative alese manual.","link":"https:\/\/medsbase.com\/ro\/underactive-thyroid-treatment\/","name":"Tratament pentru hipotiroidism","slug":"underactive-thyroid-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat\/3790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product?product_cat=3790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}